(FDP) Fresh Del Monte Produce - Overview
Stock: Fruits, Vegetables, Juices, Snacks, Poultry
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.56% |
| Yield on Cost 5y | 5.26% |
| Yield CAGR 5y | 24.47% |
| Payout Consistency | 74.3% |
| Payout Ratio | 47.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.7% |
| Relative Tail Risk | -7.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.92 |
| Alpha | 22.18 |
| Character TTM | |
|---|---|
| Beta | 0.193 |
| Beta Downside | 0.069 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.81% |
| CAGR/Max DD | 0.45 |
Description: FDP Fresh Del Monte Produce January 15, 2026
Fresh Del Monte Produce Inc. (NYSE:FDP) is a global supplier of fresh and fresh-cut fruits and vegetables, operating through three segments: Fresh & Value-Added Products, Banana, and Other Products & Services. Its portfolio spans tropical items such as pineapples and bananas, a broad range of non-tropical fruits (grapes, apples, berries, stone fruits, etc.), vegetables, avocados, and prepared foods, plus ancillary businesses in poultry, meat, and third-party freight services.
The company distributes under the flagship Del Monte brand and a suite of regional labels (e.g., UTC, Rosy, Just Juice, Bananinis, Mann’s, Nourish Bowls). Sales channels include retail chains, club stores, convenience outlets, wholesale distributors, and food-service operators, giving FDP exposure across both consumer and institutional demand cycles.
Key sector dynamics that materially affect FDP include: (1) **Seasonal inventory turnover**, typically 4–5 × per year for fresh-cut produce, driving cash-flow sensitivity to logistics efficiency; (2) **Banana price volatility**, where global supply shocks (e.g., Panama disease) can swing segment margins by ±5 %; and (3) **Consumer shift toward healthier, ready-to-eat options**, which has lifted fresh-cut sales at a CAGR of roughly 6 % over the past five years.
Given FDP’s Cayman Islands domicile, investors should also factor **currency exposure** (USD-Cayman $) and **trade policy risk** in key export markets, especially the EU’s phytosanitary standards for tropical produce.
For a deeper, data-driven view of FDP’s valuation and risk profile, you may find the analyst tools on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 80.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.51 > 1.0 |
| NWC/Revenue: 14.12% < 20% (prev 14.26%; Δ -0.14% < -1%) |
| CFO/TA 0.07 > 3% & CFO 229.5m > Net Income 80.2m |
| Net Debt (237.9m) to EBITDA (199.4m): 1.19 < 3 |
| Current Ratio: 2.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.2m) vs 12m ago 0.40% < -2% |
| Gross Margin: 8.43% > 18% (prev 0.08%; Δ 834.6% > 0.5%) |
| Asset Turnover: 138.8% > 50% (prev 135.4%; Δ 3.39% > 0%) |
| Interest Coverage Ratio: 10.68 > 6 (EBITDA TTM 199.4m / Interest Expense TTM 11.7m) |
Altman Z'' 4.53
| A: 0.20 (Total Current Assets 1.17b - Total Current Liabilities 557.7m) / Total Assets 3.07b |
| B: 0.47 (Retained Earnings 1.44b / Total Assets 3.07b) |
| C: 0.04 (EBIT TTM 124.9m / Avg Total Assets 3.11b) |
| D: 1.36 (Book Value of Equity 1.41b / Total Liabilities 1.04b) |
| Altman-Z'' Score: 4.53 = AA |
Beneish M -3.14
| DSRI: 0.92 (Receivables 441.2m/472.3m, Revenue 4.32b/4.27b) |
| GMI: 0.96 (GM 8.43% / 8.08%) |
| AQI: 1.05 (AQ_t 0.20 / AQ_t-1 0.19) |
| SGI: 1.01 (Revenue 4.32b / 4.27b) |
| TATA: -0.05 (NI 80.2m - CFO 229.5m) / TA 3.07b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of FDP shares?
Over the past week, the price has changed by -3.00%, over one month by +9.57%, over three months by +6.22% and over the past year by +27.52%.
Is FDP a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FDP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46 | 19.6% |
| Analysts Target Price | 46 | 19.6% |
| ValueRay Target Price | 43.8 | 13.7% |
FDP Fundamental Data Overview February 03, 2026
P/E Forward = 17.9211
P/S = 0.4402
P/B = 0.9406
P/EG = 1.73
Revenue TTM = 4.32b USD
EBIT TTM = 124.9m USD
EBITDA TTM = 199.4m USD
Long Term Debt = 176.7m USD (from longTermDebt, last quarter)
Short Term Debt = 38.2m USD (from shortTermDebt, last quarter)
Debt = 335.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 237.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.14b USD (1.90b + Debt 335.1m - CCE 97.2m)
Interest Coverage Ratio = 10.68 (Ebit TTM 124.9m / Interest Expense TTM 11.7m)
EV/FCF = 12.13x (Enterprise Value 2.14b / FCF TTM 176.2m)
FCF Yield = 8.24% (FCF TTM 176.2m / Enterprise Value 2.14b)
FCF Margin = 4.08% (FCF TTM 176.2m / Revenue TTM 4.32b)
Net Margin = 1.86% (Net Income TTM 80.2m / Revenue TTM 4.32b)
Gross Margin = 8.43% ((Revenue TTM 4.32b - Cost of Revenue TTM 3.95b) / Revenue TTM)
Gross Margin QoQ = 7.91% (prev 10.46%)
Tobins Q-Ratio = 0.70 (Enterprise Value 2.14b / Total Assets 3.07b)
Interest Expense / Debt = 0.45% (Interest Expense 1.50m / Debt 335.1m)
Taxrate = 17.05% (29.1m / 170.7m)
NOPAT = 103.6m (EBIT 124.9m * (1 - 17.05%))
Current Ratio = 2.09 (Total Current Assets 1.17b / Total Current Liabilities 557.7m)
Debt / Equity = 0.17 (Debt 335.1m / totalStockholderEquity, last quarter 2.01b)
Debt / EBITDA = 1.19 (Net Debt 237.9m / EBITDA 199.4m)
Debt / FCF = 1.35 (Net Debt 237.9m / FCF TTM 176.2m)
Total Stockholder Equity = 2.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.58% (Net Income 80.2m / Total Assets 3.07b)
RoE = 3.97% (Net Income TTM 80.2m / Total Stockholder Equity 2.02b)
RoCE = 5.69% (EBIT 124.9m / Capital Employed (Equity 2.02b + L.T.Debt 176.7m))
RoIC = 4.63% (NOPAT 103.6m / Invested Capital 2.24b)
WACC = 5.69% (E(1.90b)/V(2.23b) * Re(6.63%) + D(335.1m)/V(2.23b) * Rd(0.45%) * (1-Tc(0.17)))
Discount Rate = 6.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.24%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈159.3m ; Y1≈196.5m ; Y5≈334.6m
Fair Price DCF = 199.0 (EV 9.74b - Net Debt 237.9m = Equity 9.51b / Shares 47.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 3.69 | EPS CAGR: -47.36% | SUE: -1.56 | # QB: 0
Revenue Correlation: -8.23 | Revenue CAGR: 0.24% | SUE: -0.57 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.82 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=3.07 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+8.5% | Growth Revenue=-3.4%